MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202617086630 A) filed by Bristol-Myers Squibb Company on July 15, 2026, for Antibodies Targeting Il-18 Receptor Beta (il-18r?) And Related Methods.
Inventors include Su, Lin Hui; Buchwalter, Gilles; Gurbuzbalaban, Burce Ergel; Pinckney, Jason Robert; Abrial, Maryline Michle; Causton, Benjamin; Critton, David Atwater; Hassan, Tahmid Rashid; Koh, Galina Pylypiv; Nguyen, Stephanie; Pace, Samantha Elaine; Zammit, David John; Shah, Devang Praful; Parton, Anastacia; Aitken, Malinda; Ohara Hall, Aisling; and Paris, Andrew J..
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: Provided are novel antibodies and antigen-binding fragments thereof that bind interleukin-18 receptor beta (IL-18RP), along with conjugates thereof, nucleic acids encoding the same, compositions comprising the same, and methods of producing and using the same, including in the treatment of various diseases and conditions, such as inflammatory bowel disease, and other immune-mediated diseases, autoimmune diseases, inflammatory diseases, cancers, and infectious diseases.
Disclaimer: Curated by HT Syndication.
